420 related articles for article (PubMed ID: 14508824)
41. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
42. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
43. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma.
Chang SY; Fleiszer DM; Mesurolle B; El Khoury M; Omeroglu A
Breast J; 2009; 15(5):531-5. PubMed ID: 19594763
[TBL] [Abstract][Full Text] [Related]
44. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
[TBL] [Abstract][Full Text] [Related]
45. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
[TBL] [Abstract][Full Text] [Related]
46. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
47. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
48. Tumor proliferation-related markers in papillary thyroid carcinomas: correlation with histologic subtypes.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1993; 13(1):267-71. PubMed ID: 8097390
[TBL] [Abstract][Full Text] [Related]
49. [Anaplastic carcinoma of the thyroid at the Instituto Nacional de la Nutrición Salvador Zubirán].
Sierra M; Gamboa-Domínguez A; Herrera MF; Barredo-Prieto B; Alvarado de la Barrera C; Llorente L; Pérez-Enriquez B; Rivera R; González O; Rull JA
Rev Invest Clin; 1997; 49(2):97-103. PubMed ID: 9380971
[TBL] [Abstract][Full Text] [Related]
50. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
51. Prognostic importance of sclerosing variant in papillary thyroid carcinoma.
Falvo L; Giacomelli L; D'Andrea V; Marzullo A; Guerriero G; de Antoni E
Am Surg; 2006 May; 72(5):438-44. PubMed ID: 16719201
[TBL] [Abstract][Full Text] [Related]
52. Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma.
Kleer CG; Giordano TJ; Merino MJ
Mod Pathol; 2000 Jul; 13(7):742-6. PubMed ID: 10912933
[TBL] [Abstract][Full Text] [Related]
53. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis.
Cornetta AJ; Russell JP; Cunnane M; Keane WM; Rothstein JL
Laryngoscope; 2002 Feb; 112(2):238-42. PubMed ID: 11889377
[TBL] [Abstract][Full Text] [Related]
54. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
He F; Li H; Li WS; Dong XH
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
[TBL] [Abstract][Full Text] [Related]
55. Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns?
Pilotti S; Collini P; Manzari A; Marubini E; Rilke F
Semin Diagn Pathol; 1995 Aug; 12(3):249-55. PubMed ID: 8545591
[TBL] [Abstract][Full Text] [Related]
56. The relation between pure papillary and follicular variant in papillary thyroid carcinoma.
Yuksel O; Kurukahvecioglu O; Ege B; Ekinci O; Aydin A; Poyraz A; Tezel E; Taneri F
Endocr Regul; 2008 Mar; 42(1):29-33. PubMed ID: 18333702
[TBL] [Abstract][Full Text] [Related]
57. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
58. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
[TBL] [Abstract][Full Text] [Related]
59. Squamous cell carcinoma associated with tall cell variant of papillary carcinoma of the thyroid.
Ashraf MJ; Azarpira N; Khademi B; Peiravi M
Indian J Pathol Microbiol; 2010; 53(3):548-50. PubMed ID: 20699523
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
Di Renzo MF; Olivero M; Ferro S; Prat M; Bongarzone I; Pilotti S; Belfiore A; Costantino A; Vigneri R; Pierotti MA
Oncogene; 1992 Dec; 7(12):2549-53. PubMed ID: 1334253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
